Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease
- 1 October 2003
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 144 (10) , 4241-4249
Abstract
The discovery of a second estrogen receptor (ER), called ERβ, in 1996 sparked intense interest within the scientific community to discover its role in mediating estrogen action. However, despite more than 6 yr of research into the function of this receptor, its physiological role in mediating estrogen action remains unclear and controversial. We have developed a series of highly selective agonists for ERβ and have characterized their activity in several clinically relevant rodent models of human disease. The activity of one such compound, ERB-041, is reported here. We conclude from these studies that ERβ does not mediate the bone-sparing activity of estrogen on the rat skeleton and that it does not affect ovulation or ovariectomy-induced weight gain. In addition, these compounds are nonuterotrophic and nonmammotrophic. However, ERB-041 has a dramatic beneficial effect in the HLA-B27 transgenic rat model of inflammatory bowel disease and the Lewis rat adjuvant-induced arthritis model. Daily oral doses as low as 1 mg/kg reverse the chronic diarrhea of HLA-B27 transgenic rats and dramatically improve histological disease scores in the colon. The same dosing regimen in the therapeutic adjuvant-induced arthritis model reduces joint scores from 12 (maximal inflammation) to 1 over a period of 10 d. Synovitis and Mankin (articular cartilage) histological scores are also significantly lowered (50–75%). These data suggest that one function of ERβ may be to modulate the immune response, and that ERβ-selective ligands may be therapeutically useful agents to treat chronic intestinal and joint inflammation.Keywords
This publication has 37 references indexed in Scilit:
- Estrogen Receptor-α Mediates the Protective Effects of Estrogen Against Vascular InjuryCirculation Research, 2002
- Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout miceCurrent Opinion in Pharmacology, 2001
- Estrogen Receptor-β Potency-Selective Ligands: Structure−Activity Relationship Studies of Diarylpropionitriles and Their Acetylene and Polar AnaloguesJournal of Medicinal Chemistry, 2001
- Expression of genes for estrogen receptors α and β in human articular chondrocytesOsteoarthritis and Cartilage, 1999
- Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- ERβ a Novel Estrogen Receptor Offers the Potential for New Drug DevelopmentTrends in Endocrinology & Metabolism, 1998
- A novel human estrogen receptor β: identification and functional analysis of additional N-terminal amino acidsThe Journal of Steroid Biochemistry and Molecular Biology, 1998
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- Rheumatoid-Like Joint Lesions in Rabbits Injected Intravenously with Bovine SerumInternational Archives of Allergy and Immunology, 1977